Synthesis and bio-molecular study of (+)-N-Acetyl-α-amino acid dehydroabietylamine derivative for the selective therapy of hepatocellular carcinoma

ArticleAçık Erişim

Özet

Background: The purpose of present work is to synthesize novel (+)-Dehydroabietylamine derivatives (DAAD) using N-acetyl-α-amino acid conjugates and determine its cytotoxic effects on hepatocellular carcinoma cells. Methods: An analytical study was conducted to explore cytotoxic activity of DAAD on hepatocellular carcinoma cell lines. The cytotoxicity effect was recorded using sulforhodamine B technique. Cell cycle analysis was performed using Propidium Iodide (PI) staining. Based on cell morphology, anti growth activity and microarray findings of DAAD2 treatment, Comet assay, Annexin V/PI staining, Immunoperoxidase assay and western blots were performed accoringly. Results: Hep3B cells were found to be the most sensitive with IC50 of 2.00 ± 0.4 μM against (+)-N-(N-Acetyl-L-Cysteine)-dehydroabietylamine as DAAD2. In compliance to time dependent morphological changes of low cellular confluence, detachment and rounding of DAAD2 treated cells; noticeable changes in G2/M phase were recorded may be leading to cell cycle cessation. Up-regulation (5folds) of TUBA1A gene in Hep3B cells was determined in microarray experiments. Apoptotic mode of cell death was evaluated using standardized staining procedures including comet assay and annexin V/PI staining, Immuno-peroxidase assay. Using western blotting technique, caspase dependant apoptotic mode of cell death was recorded against Hep3B cell line. Conclusion: It is concluded that a novel DAAD2 with IC50 values less than 8 μM can induce massive cell attenuation following caspase dependent apoptotic cell death in Hep3B cells. Moreover, the corelation study indicated that DAAD2 may have vital influence on cell prolifration properties. © 2016 The Author(s).

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14750Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1186/s12885-016-2942-5Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorMustufa, Muhammad Ayaz
dc.contributor.authorOzen, Cigdem
dc.contributor.authorHashmi, Imran Ali
dc.contributor.authorAslam, Afshan
dc.contributor.authorBaig, Jameel Ahmed
dc.contributor.authorYildiz, Gokhan
dc.contributor.authorMuhammad, Shoaib
dc.contributor.authorSolangi, Imam Bakhsh
dc.contributor.authorul Hasan Naqvi, Naim
dc.contributor.authorOzturk, Mehmet
dc.contributor.authorAli, Firdous Imran
dc.date.accessioned2026-10-18T20:29:33.374640613Z
dc.date.available2026-10-18T20:29:33.374640613Z
dc.date.issued2016
dc.description.abstractBackground: The purpose of present work is to synthesize novel (+)-Dehydroabietylamine derivatives (DAAD) using N-acetyl-α-amino acid conjugates and determine its cytotoxic effects on hepatocellular carcinoma cells. Methods: An analytical study was conducted to explore cytotoxic activity of DAAD on hepatocellular carcinoma cell lines. The cytotoxicity effect was recorded using sulforhodamine B technique. Cell cycle analysis was performed using Propidium Iodide (PI) staining. Based on cell morphology, anti growth activity and microarray findings of DAAD2 treatment, Comet assay, Annexin V/PI staining, Immunoperoxidase assay and western blots were performed accoringly. Results: Hep3B cells were found to be the most sensitive with IC50 of 2.00 ± 0.4 μM against (+)-N-(N-Acetyl-L-Cysteine)-dehydroabietylamine as DAAD2. In compliance to time dependent morphological changes of low cellular confluence, detachment and rounding of DAAD2 treated cells; noticeable changes in G2/M phase were recorded may be leading to cell cycle cessation. Up-regulation (5folds) of TUBA1A gene in Hep3B cells was determined in microarray experiments. Apoptotic mode of cell death was evaluated using standardized staining procedures including comet assay and annexin V/PI staining, Immuno-peroxidase assay. Using western blotting technique, caspase dependant apoptotic mode of cell death was recorded against Hep3B cell line. Conclusion: It is concluded that a novel DAAD2 with IC50 values less than 8 μM can induce massive cell attenuation following caspase dependent apoptotic cell death in Hep3B cells. Moreover, the corelation study indicated that DAAD2 may have vital influence on cell prolifration properties. © 2016 The Author(s).
dc.description.sponsorshipThe corresponding author received 1 year research fellowship grant from TUBITAK, Turkey. One of the authors (Ali FI) received a grant from Higher Education Commission of Pakistan. One of the authors (Ozen C) was supported by Turkish Academy of Sciences (TÜBA) with DSAP.
dc.identifier.doi10.1186/s12885-016-2942-5
dc.identifier.issn1471-2407
dc.identifier.issue1
dc.identifier.pmcidPMC5109647
dc.identifier.pmid27842576
dc.identifier.scopus2-s2.0-84996548612
dc.identifier.startpage883
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14750
dc.identifier.volume16
dc.language.isoen
dc.publisherBioMed Central Ltd.
dc.relation.ispartofBMC Cancer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectApoptosis
dc.subjectConnectivity map
dc.subjectCytotoxicity
dc.subjectDehydroabietylamine derivatives
dc.subjectHepatocellular carcinoma
dc.subjectAntineoplastic Agents
dc.subjectCarcinoma, Hepatocellular
dc.subjectCaspases
dc.subjectCell Cycle
dc.subjectCell Line, Tumor
dc.subjectCell Proliferation
dc.subjectDiterpenes, Abietane
dc.subjectG2 Phase Cell Cycle Checkpoints
dc.subjectHumans
dc.subjectInhibitory Concentration 50
dc.subjectLiver Neoplasms
dc.subjectcamptothecin
dc.subjectcaspase
dc.subjectcytotoxic agent
dc.subjectn (n acetyl cysteine)dehydroabietylamine
dc.subjectunclassified drug
dc.subjectabietane derivative
dc.subjectantineoplastic agent
dc.subjectdehydroabietylamine
dc.subjectArticle
dc.subjectattenuation
dc.subjectcell structure
dc.subjectcontrolled study
dc.subjectdrug cytotoxicity
dc.subjectdrug effect
dc.titleSynthesis and bio-molecular study of (+)-N-Acetyl-α-amino acid dehydroabietylamine derivative for the selective therapy of hepatocellular carcinoma
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus6
rdl.departmentDepartment of Medical Biology, Erzincan University Faculty of Medicine, Erzincan, 24100, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexPUBMED